Intramuscular injection of adenoviral hepatocyte growth factor at a distal site ameliorates dextran sodium sulfate-induced colitis in mice

Yuge,Kentaro; Takahashi,Tomoyuki; Khai,Ngin Cin; Goto,Kazuko; Fujiwara,Takako; Fujiwara,Hisayoshi; Kosai,Ken-Ichiro

doi:10.3892/ijmm.2014.1686

Intramuscular injection of adenoviral hepatocyte growth factor at a distal site ameliorates dextran sodium sulfate-induced colitis in mice

Authors:
- Kentaro Yuge
- Tomoyuki Takahashi
- Ngin Cin Khai
- Kazuko Goto
- Takako Fujiwara
- Hisayoshi Fujiwara
- Ken-Ichiro Kosai
View Affiliations

Affiliations: Department of Gene Therapy and Regenerative Medicine, Graduate School of Medicine, Gifu University, Gifu 502-1194, Japan, Department of Food Science, Kyoto Women's University, Kyoto 605-8501, Japan
Published online on: March 6, 2014 https://doi.org/10.3892/ijmm.2014.1686
Pages: 1064-1074
Copyright: © Yuge et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Inflammatory bowel disease (IBD) severely affects the quality of life of patients. At present, there is no clinical solution for this condition; therefore, there is a need for innovative therapies for IBD. Hepatocyte growth factor (HGF) exerts various biological activities in various organs. However, a clinically applicable and effective HGF-based therapy for IBD has yet to be developed. In this study, we examined the therapeutic effect of injecting an adenoviral vector encoding the human HGF gene (Ad.HGF) into the hindlimbs of mice with dextran sodium sulfate (DSS)-induced colitis. Plasma levels of circulating human HGF (hHGF) were measured in injected mice. The results showed that weight loss and colon shortening were significantly lower in Ad.HGF-infected mice as compared to control (Ad.LacZ-infected) colitic mice. Additionally, inflammation and crypt scores were significantly reduced in the entire length of the colon, particularly in the distal section. This therapeutic effect was associated with increased cell proliferation and an antiapoptotic effect, as well as a reduction in the number of CD4+ cells and a decreased CD4/CD8 ratio. The levels of inflammatory, as well as Th1 and Th2 cytokines were higher in Ad.HGF-infected mice as compared to the control colitic mice. Thus, systemically circulating hHGF protein, produced by an adenovirally transduced hHGF gene introduced at distal sites in the limbs, significantly ameliorated DSS-induced colitis by promoting cell proliferation (i.e., regeneration), preventing apoptosis, and immunomodulation. Owing to its clinical feasibility and potent therapeutic effects, this method may be developed into a clinical therapy for treating IBD.

View Figures

View References

1	Hisamatsu T, Kanai T, Mikami Y, Yoneno K, Matsuoka K and Hibi T: Immune aspects of the pathogenesis of inflammatory bowel disease. Pharmacol Ther. 137:283–297. 2013. View Article : Google Scholar : PubMed/NCBI
2	Bernklev T, Jahnsen J, Aadland E, et al: Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol. 39:365–373. 2004.PubMed/NCBI
3	Burger D and Travis S: Conventional medical management of inflammatory bowel disease. Gastroenterology. 140:1827–1837. e18222011. View Article : Google Scholar : PubMed/NCBI
4	Nakamura T, Nawa K and Ichihara A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 122:1450–1459. 1984. View Article : Google Scholar : PubMed/NCBI
5	Russell WE, McGowan JA and Bucher NL: Partial characterization of a hepatocyte growth factor from rat platelets. J Cell Physiol. 119:183–192. 1984. View Article : Google Scholar : PubMed/NCBI
6	Thaler FJ and Michalopoulos GK: Hepatopoietin A: partial characterization and trypsin activation of a hepatocyte growth factor. Cancer Res. 45:2545–2549. 1985.PubMed/NCBI
7	Gohda E, Tsubouchi H, Nakayama H, et al: Human hepatocyte growth factor in plasma from patients with fulminant hepatic failure. Exp Cell Res. 166:139–150. 1986. View Article : Google Scholar : PubMed/NCBI
8	Nakamura T, Nishizawa T, Hagiya M, et al: Molecular cloning and expression of human hepatocyte growth factor. Nature. 342:440–443. 1989. View Article : Google Scholar : PubMed/NCBI
9	Miyazawa K, Tsubouchi H, Naka D, et al: Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun. 163:967–973. 1989. View Article : Google Scholar : PubMed/NCBI
10	Matsumoto K and Nakamura T: Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem Biophys Res Commun. 239:639–644. 1997. View Article : Google Scholar : PubMed/NCBI
11	Matsuno M, Shiota G, Umeki K, Kawasaki H, Kojo H and Miura K: Clinical evaluation of hepatocyte growth factor in patients with gastrointestinal and pancreatic diseases with special reference to inflammatory bowel disease. Res Commun Mol Pathol Pharmacol. 97:25–37. 1997.PubMed/NCBI
12	Kitamura S, Kondo S, Shinomura Y, et al: Expression of hepatocyte growth factor and c-met in ulcerative colitis. Inflamm Res. 49:320–324. 2000. View Article : Google Scholar : PubMed/NCBI
13	Srivastava M, Zurakowski D, Cheifetz P, Leichtner A and Bousvaros A: Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 33:548–553. 2001. View Article : Google Scholar : PubMed/NCBI
14	Ortega-Cava CF, Ishihara S, Kawashima K, et al: Hepatocyte growth factor expression in dextran sodium sulfate-induced colitis in rats. Dig Dis Sci. 47:2275–2285. 2002. View Article : Google Scholar : PubMed/NCBI
15	Dignass AU, Lynch-Devaney K and Podolsky DK: Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun. 202:701–709. 1994. View Article : Google Scholar : PubMed/NCBI
16	Numata M, Ido A, Moriuchi A, et al: Hepatocyte growth factor facilitates the repair of large colonic ulcers in 2,4,6-trinitrobenzene sulfonic acid-induced colitis in rats. Inflamm Bowel Dis. 11:551–558. 2005. View Article : Google Scholar : PubMed/NCBI
17	Tahara Y, Ido A, Yamamoto S, et al: Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther. 307:146–151. 2003. View Article : Google Scholar : PubMed/NCBI
18	Ohda Y, Hori K, Tomita T, et al: Effects of hepatocyte growth factor on rat inflammatory bowel disease models. Dig Dis Sci. 50:914–921. 2005. View Article : Google Scholar : PubMed/NCBI
19	Setoyama H, Ido A, Numata M, et al: Repeated enemas with hepatocyte growth factor selectively stimulate epithelial cell proliferation of injured mucosa in rats with experimental colitis. Life Sci. 89:269–275. 2011. View Article : Google Scholar : PubMed/NCBI
20	Arthur LG, Schwartz MZ, Kuenzler KA and Birbe R: Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease. J Pediatr Surg. 39:139–143. 2004. View Article : Google Scholar
21	Mukoyama T, Kanbe T, Murai R, et al: Therapeutic effect of adenoviral-mediated hepatocyte growth factor gene administration on TNBS-induced colitis in mice. Biochem Biophys Res Commun. 329:1217–1224. 2005. View Article : Google Scholar : PubMed/NCBI
22	Hanawa T, Suzuki K, Kawauchi Y, et al: Attenuation of mouse acute colitis by naked hepatocyte growth factor gene transfer into the liver. J Gene Med. 8:623–635. 2006. View Article : Google Scholar : PubMed/NCBI
23	Kanbe T, Murai R, Mukoyama T, et al: Naked gene therapy of hepatocyte growth factor for dextran sulfate sodium-induced colitis in mice. Biochem Biophys Res Commun. 345:1517–1525. 2006. View Article : Google Scholar : PubMed/NCBI
24	Kanayama M, Takahara T, Yata Y, et al: Hepatocyte growth factor promotes colonic epithelial regeneration via Akt signaling. Am J Physiol Gastrointest Liver Physiol. 293:G230–G239. 2007. View Article : Google Scholar : PubMed/NCBI
25	Li Y, Takemura G, Kosai K, et al: Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation. 107:2499–2506. 2003. View Article : Google Scholar
26	Chen SH, Chen XH, Wang Y, et al: Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci USA. 92:2577–2581. 1995. View Article : Google Scholar : PubMed/NCBI
27	Takahashi T, Kawai T, Ushikoshi H, et al: Identification and isolation of embryonic stem cell-derived target cells by adenoviral conditional targeting. Mol Ther. 14:673–683. 2006. View Article : Google Scholar : PubMed/NCBI
28	Okabe Y, Kusaga A, Takahashi T, et al: Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome. Brain Res. 1360:17–27. 2010. View Article : Google Scholar : PubMed/NCBI
29	Horikawa Y, Wang Y, Nagano S, et al: Assessment of an altered E1B promoter on the specificity and potency of triple-regulated conditionally replicating adenoviruses: implications for the generation of ideal m-CRAs. Cancer Gene Ther. 18:724–733. 2011. View Article : Google Scholar : PubMed/NCBI
30	Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y and Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 98:694–702. 1990.PubMed/NCBI
31	Tomoyose M, Mitsuyama K, Ishida H, Toyonaga A and Tanikawa K: Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis. Scand J Gastroenterol. 33:435–440. 1998. View Article : Google Scholar : PubMed/NCBI
32	Kanauchi O, Nakamura T, Agata K, Mitsuyama K and Iwanaga T: Effects of germinated barley foodstuff on dextran sulfate sodium-induced colitis in rats. J Gastroenterol. 33:179–188. 1998. View Article : Google Scholar : PubMed/NCBI
33	Yuge K, Takahashi T, Nagano S, et al: Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatoma. Int J Oncol. 27:77–85. 2005.PubMed/NCBI
34	Kamisasanuki T, Tokushige S, Terasaki H, et al: Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: a novel antiangiogenic therapy. Biochem Biophys Res Commun. 413:128–135. 2011. View Article : Google Scholar
35	Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA and Sedergran DJ: Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci. 38:1722–1734. 1993. View Article : Google Scholar : PubMed/NCBI
36	Li Y, Takemura G, Kosai K, et al: Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Circ Res. 95:627–636. 2004. View Article : Google Scholar : PubMed/NCBI
37	Iwamoto M, Koji T, Makiyama K, Kobayashi N and Nakane PK: Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol. 180:152–159. 1996. View Article : Google Scholar : PubMed/NCBI
38	Sträter J, Wellisch I, Riedl S, et al: CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology. 113:160–167. 1997.PubMed/NCBI
39	Rogler G and Andus T: Cytokines in inflammatory bowel disease. World J Surg. 22:382–389. 1998. View Article : Google Scholar : PubMed/NCBI
40	Egger B, Bajaj-Elliott M, MacDonald TT, Inglin R, Eysselein VE and Büchler MW: Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion. 62:240–248. 2000. View Article : Google Scholar : PubMed/NCBI
41	Tomanin R and Scarpa M: Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction. Curr Gene Ther. 4:357–372. 2004. View Article : Google Scholar : PubMed/NCBI
42	Boulaiz H, Marchal JA, Prados J, Melguizo C and Aránega A: Non-viral and viral vectors for gene therapy. Cell Mol Biol (Noisy-le-grand). 51:3–22. 2005.
43	Oh K, Iimuro Y, Takeuchi M, et al: Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model. Am J Physiol Gastrointest Liver Physiol. 288:G729–G735. 2005. View Article : Google Scholar : PubMed/NCBI
44	Shiota G, Kawasaki H, Nakamura T and Schmidt EV: Characterization of double transgenic mice expressing hepatocye growth factor and transforming growth factor alpha. Res Commun Mol Pathol Pharmacol. 90:17–24. 1995.PubMed/NCBI
45	Sakata H, Takayama H, Sharp R, Rubin JS, Merlino G and LaRochelle WJ: Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ. 7:1513–1523. 1996.
46	Chen P, Kovesdi I and Bruder JT: Effective repeat administration with adenovirus vectors to the muscle. Gene Ther. 7:587–595. 2000. View Article : Google Scholar : PubMed/NCBI
47	Jeschke MG, Bolder U, Finnerty CC, et al: The effect of hepatocyte growth factor on gut mucosal apoptosis and proliferation, and cellular mediators after severe trauma. Surgery. 138:482–489. 2005. View Article : Google Scholar : PubMed/NCBI
48	Futamatsu H, Suzuki J, Mizuno S, et al: Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines. Circ Res. 96:823–830. 2005. View Article : Google Scholar : PubMed/NCBI
49	Kuroiwa T, Iwasaki T, Imado T, Sekiguchi M, Fujimoto J and Sano H: Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease. Arthritis Res Ther. 8:R1232006. View Article : Google Scholar : PubMed/NCBI
50	Okunishi K, Dohi M, Nakagome K, et al: A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol. 175:4745–4753. 2005. View Article : Google Scholar : PubMed/NCBI
51	Ito W, Takeda M, Tanabe M, et al: Anti-allergic inflammatory effects of hepatocyte growth factor. Int Arch Allergy Immunol. 146(Suppl 1): S82–S87. 2008. View Article : Google Scholar
52	Okunishi K, Dohi M, Fujio K, et al: Hepatocyte growth factor significantly suppresses collagen-induced arthritis in mice. J Immunol. 179:5504–5513. 2007. View Article : Google Scholar : PubMed/NCBI